Hi everyone, this is KalaGhazi and today I will be talking about Reata that just rocketed 200% yesterday.
Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease called Friedreich’s ataxia.
Shares of Reata have surged 200.3%...
Stock: $RETA (Reata Pharma)
Stock Price: $169.00
Position: Short
Type: Options (Buy Put)
Play: Swing
Risk: Very-High
Date: 11/15
Strike: $160
Limit: $17.20
Contracts: 1
Equity: $1,720
*Note: This short is expensive and will open up negative if you have to get filled higher than the market.
This is a 1 of 2 short position open.
This stock recently beat a...